In the present study, somatic PIK3CA mutations were found in 24.3% of tumours, and ERBB family mutations were found in 10.8% of tumours, with a similar distribution in ER-positive or ER-negative tumours, which confirms results of previous studies [17, 21, 22]. The gene discussed is PIK3CA; the disease is neoplasm.